Eyebright Medical Earnings Estimate

688050 Stock   88.50  1.78  1.97%   
By analyzing Eyebright Medical's earnings estimates, investors can diagnose different trends across Eyebright Medical's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Eyebright Medical Technology is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Eyebright Medical is projected to generate 0.0 in earnings per share on the 31st of December 2024. Eyebright Medical earnings estimates module stress-tests analyst consensus about projected Eyebright Medical Technology EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as Eyebright Medical, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Eyebright Medical's earnings estimates, investors can diagnose different trends across Eyebright Medical's analyst sentiment over time as well as compare current estimates against different timeframes. The current year's Gross Profit is expected to grow to about 759.1 M
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Eyebright Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Eyebright Medical Earnings per Share Projection vs Actual

About Eyebright Medical Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Eyebright Medical earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Eyebright Medical estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Eyebright Medical fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings647.2 M679.5 M

Currently Active Assets on Macroaxis

Other Information on Investing in Eyebright Stock

Eyebright Medical financial ratios help investors to determine whether Eyebright Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eyebright with respect to the benefits of owning Eyebright Medical security.